{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:21:32Z","timestamp":1792092092619,"version":"4.4.0"},"reference-count":92,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T00:00:00Z","timestamp":1623715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Melanoma develops from malignant transformations of the pigment-producing melanocytes. If located in the basal layer of the skin epidermis, melanoma is referred to as cutaneous, which is more frequent. However, as melanocytes are be found in the eyes, ears, gastrointestinal tract, genitalia, urinary system, and meninges, cases of mucosal melanoma or other types (e.g., ocular) may occur. The incidence and morbidity of cutaneous melanoma (cM) are constantly increasing worldwide. Australia and New Zealand are world leaders in this regard with a morbidity rate of 54\/100,000 and a mortality rate of 5.6\/100,000 for 2015. The aim of this review is to consolidate and present the data related to the aetiology and pathogenesis of cutaneous melanoma, thus rendering them easier to understand. In this article we will discuss these problems and the possible impacts on treatment for this disease.<\/jats:p>","DOI":"10.3390\/ijms22126395","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T11:00:33Z","timestamp":1623754833000},"page":"6395","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":157,"title":["Aetiology and Pathogenesis of Cutaneous Melanoma: Current Concepts and Advances"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4104-948X","authenticated-orcid":false,"given":"Strahil","family":"Strashilov","sequence":"first","affiliation":[{"name":"Department of Plastic Restorative, Reconstructive and Aesthetic Surgery, University Hospital \u201cDr. Georgi Stranski\u201d, Medical University Pleven, 5800 Pleven, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7719-382X","authenticated-orcid":false,"given":"Angel","family":"Yordanov","sequence":"additional","affiliation":[{"name":"Clinic of Gynecologic Oncology, University Hospital \u201cDr. Georgi Stranski\u201d, Medical University Pleven, 5800 Pleven, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1101\/gad.12.22.3467","article-title":"Malignant melanoma: Modern black plague and genetic black box","volume":"12","author":"Chin","year":"1998","journal-title":"Genes Dev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3857\/roj.2020.00318","article-title":"Clinical management of uveal melanoma: A comprehensive review with a treatment algorithm","volume":"38","author":"Sayan","year":"2020","journal-title":"Radiat. Oncol. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1007\/s10147-020-01759-x","article-title":"Epidemiology and survival outcomes of primary gastrointestinal melanoma: A SEER-based population study","volume":"25","author":"Zheng","year":"2020","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jss.2020.11.048","article-title":"Presentation, Management, and Prognosis of Primary Gastrointestinal Melanoma: A Population-Based Study","volume":"260","author":"Kahl","year":"2021","journal-title":"J. Surg. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40257-019-00487-x","article-title":"Malignant Melanoma of the Vulva and Vagina: A US Population-Based Study of 1863 Patients","volume":"21","author":"Wohlmuth","year":"2019","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_7","first-page":"834","article-title":"Melanoma of female genital tract: A clinicopathological analysis of 5 cases","volume":"49","author":"Sun","year":"2020","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"153095","DOI":"10.1016\/j.prp.2020.153095","article-title":"Primary melanoma of the urinary tract; Clinicopathologic and molecular review of a case series","volume":"216","author":"Acikalin","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"101542","DOI":"10.1016\/j.eucr.2020.101542","article-title":"Primary malignant melanoma of the urethra in women: About a case","volume":"35","author":"Ido","year":"2021","journal-title":"Urol. Case Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.abd.2019.11.002","article-title":"Primary melanoma of leptomeninge in a patient with giant congenital melanocytic nevus","volume":"95","author":"Machado","year":"2020","journal-title":"An. Bras. Dermatol."},{"key":"ref_11","first-page":"1","article-title":"Multifocal primary amelanotic meningeal melanomas mimicking lymphoma: A case report and literature review","volume":"15","author":"Cao","year":"2020","journal-title":"Br. J. Neurosurg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/bjd.15510","article-title":"The global burden of melanoma: Results from the Global Burden of Disease Study 2015","volume":"177","author":"Karimkhani","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1073\/pnas.0504497102","article-title":"Ultraviolet A radiation is highly mutagenic in cells that are unable to repair 7,8-dihydro-8-oxoguanine in Saccharomyces cerevisiae","volume":"102","author":"Kozmin","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0300-483X(03)00150-1","article-title":"UV-induced skin damage","volume":"189","author":"Ichihashi","year":"2003","journal-title":"Toxicology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.suc.2019.09.005","article-title":"Epidemiology and Risk Factors of Melanoma","volume":"100","author":"Carr","year":"2020","journal-title":"Surg. Clin. North Am."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1515\/hsz-2018-0327","article-title":"Oxidative stress and antioxidants in the pathophysiology of malignant melanoma","volume":"400","author":"Obrador","year":"2019","journal-title":"Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/php.13278","article-title":"Oxidative Stress and Genotoxicity in Melanoma Induction: Impact on Repair Rather Than Formation of DNA Damage?","volume":"96","author":"Douki","year":"2020","journal-title":"Photochem. Photobiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/em.22176","article-title":"Roles of UVA radiation and DNA damage responses in melanoma pathogenesis","volume":"59","author":"Khan","year":"2018","journal-title":"Environ. Mol. Mutagenesis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41591-018-0265-6","article-title":"Ultraviolet radiation\u2013induced DNA damage is prognostic for outcome in melanoma","volume":"25","author":"Trucco","year":"2019","journal-title":"Nat. Med."},{"key":"ref_20","first-page":"32","article-title":"Lentigos, Melanocytic Naevi and Melanoma","volume":"Volume 54","author":"Bishop","year":"2010","journal-title":"Rook\u2019s Textbook of Dermatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1684\/ejd.2017.3129","article-title":"Clinical assessment of skin phototypes: Watch your words!","volume":"27","author":"Trakatelli","year":"2017","journal-title":"Eur. J. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.det.2016.08.001","article-title":"Melanocytic Nevi and the Genetic and Epigenetic Control of Oncogene-Induced Senescence","volume":"35","author":"Huang","year":"2017","journal-title":"Dermatol. Clin."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1038\/onc.2017.189","article-title":"Melanocytic nevi and melanoma: Unraveling a complex relationship","volume":"36","author":"Damsky","year":"2017","journal-title":"Oncogene"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1365-4362.2001.01132.x","article-title":"Risk factors for cutaneous melanoma: A case-control study in Argentina","volume":"40","author":"Loria","year":"2001","journal-title":"Int. J. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/jdv.15964","article-title":"The association between pesticide use and cutaneous melanoma: A systematic review and meta-analysis","volume":"34","author":"Stanganelli","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/archdermatol.2011.44","article-title":"Increases in melanoma among adolescent girls and young women in California: Trends by socioeconomic status and UV radiation exposure","volume":"147","author":"Hausauer","year":"2011","journal-title":"Arch. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2340\/00015555-3491","article-title":"Melanoma Epidemiology and Sun Exposure","volume":"100","author":"Raimondi","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ijc.11360","article-title":"Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: Rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia","volume":"107","author":"Bray","year":"2003","journal-title":"Int. J. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1600-0463.2007.apm_855.xml.x","article-title":"The genome and epigenome of malignant melanoma","volume":"115","author":"Dahl","year":"2007","journal-title":"Apmis"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/phpp.12329","article-title":"Mechanisms and prevention of UV-induced melanoma. Photodermatol","volume":"34","author":"Sample","year":"2018","journal-title":"Photoimmunol. Photomed."},{"key":"ref_31","first-page":"210","article-title":"Pathways to Melanoma. Semin. Cutan","volume":"29","author":"Ko","year":"2010","journal-title":"Med. Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.2147\/OTT.S117121","article-title":"NRAS-mutant melanoma: Current challenges and future prospect","volume":"10","author":"Adelantado","year":"2017","journal-title":"OncoTargets Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.cell.2006.12.045","article-title":"Central Role of p53 in the Suntan Response and Pathologic Hyperpigmentation","volume":"128","author":"Cui","year":"2007","journal-title":"Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s12094-006-0046-4","article-title":"Molecular biology of malignant melanoma and other cutaneous tumors","volume":"8","author":"Pons","year":"2006","journal-title":"Clin. Transl. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/cancers12020482","article-title":"Current Advances in the Treatment of BRAF-Mutant Melanoma","volume":"12","author":"Hima","year":"2020","journal-title":"Cancers"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"6222","DOI":"10.4161\/sgtp.1.3.14344","article-title":"Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis","volume":"1","author":"Kim","year":"2010","journal-title":"Small GTPases"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1100\/2012\/252457","article-title":"PTEN Gene: A Model for Genetic Diseases in Dermatology","volume":"2012","author":"Romano","year":"2012","journal-title":"Sci. World J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.suc.2019.09.006","article-title":"Role of Heredity in Melanoma Susceptibility: A Primer for the Practicing Surgeon","volume":"100","author":"Abdo","year":"2020","journal-title":"Surg. Clin. North Am."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2015.08.038","article-title":"Hereditary Melanoma: Update on Syndromes and Management\u2014Genetics of familial atypical multiple mole melanoma syndrome","volume":"74","author":"Soura","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.critrevonc.2004.11.001","article-title":"Cutaneous melanoma: Pathogenesis and rationale for chemoprevention","volume":"53","author":"Demierre","year":"2005","journal-title":"Crit. Rev. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1365-2133.2011.10551.x","article-title":"Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanoma","volume":"165","author":"Nikolaou","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/CMR.0b013e328351fa4d","article-title":"A brief history of melanoma: From mummies to mutations","volume":"22","author":"Rebecca","year":"2012","journal-title":"Melanoma Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/bjd.14485","article-title":"CDKN2A mutations with p14 loss predisposing to multiple nerve sheath tumours, melanoma, dysplastic naevi and internal malignancies: A case series and review of the literature","volume":"175","author":"Sargen","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmedgenet-2015-103150","article-title":"Melanoma genetics","volume":"53","author":"Read","year":"2016","journal-title":"J. Med. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10555-017-9661-5","article-title":"Identification, genetic testing, and management of hereditary melanoma","volume":"36","author":"Leachman","year":"2017","journal-title":"Cancer Metastasis Rev."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Newton-Bishop, J., Bishop, D., and Harland, M. (2020). Melanoma Genomics. Acta Derm Venereol.","DOI":"10.2340\/00015555-3493"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Dalmasso, B., and Ghiorzo, P. (2020). Evolution of approaches to identify melanoma missing heritability. Expert. Rev. Mol. Diagn.","DOI":"10.1080\/14737159.2020.1738221"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.bjps.2017.03.005","article-title":"High-risk cutaneous malignancies and immunosuppression: Challenges for the reconstructive surgeon in the renal transplant population","volume":"70","author":"Kearney","year":"2017","journal-title":"J. Plast. Reconstr. Aesthetic Surg."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.mayocp.2012.04.018","article-title":"Melanoma in Immunosuppressed Patients","volume":"87","author":"Kubica","year":"2012","journal-title":"Mayo Clin. Proc."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Metodiev, K. (2015). Principles of cancer immunobiology and immunotherapy of solid tumors. Immunopathology and Immunomodulation.","DOI":"10.5772\/59217"},{"key":"ref_51","unstructured":"Ricci, F., Paradisi, A., Fania, L., Pallotta, S., Di Lella, G., Sobrino, L., Panebianco, A., and Abeni, D. (2019). High melanoma risk in non-melanoma skin cancer patients under age 40: A large retrospective cohort study. G. Ital. Dermatol. Venereol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/ajd.12278","article-title":"An Australian cohort of 210 patients with multiple invasive squamous cell carcinomas: Risk factors and associated increased risk of melanoma and internal malignancies","volume":"57","author":"Banan","year":"2015","journal-title":"Australas. J. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.cmr.0000195699.35143.df","article-title":"The polymerization of melanin: A poorly understood phenomenon with egregious biological implications","volume":"16","author":"Sarangarajan","year":"2006","journal-title":"Melanoma Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1158\/1078-0432.CCR-03-0638","article-title":"Etiologic pathogenesis of melanoma: A unifying hypothesis for the missing attributable risk","volume":"15","author":"Meyskens","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5858\/arpa.2019-0561-RA","article-title":"The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway","volume":"144","author":"Elder","year":"2020","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_56","first-page":"1885","article-title":"Melanoma","volume":"Volume 2","author":"Bolognia","year":"2012","journal-title":"Dermatology"},{"key":"ref_57","unstructured":"Devita, V., Hellman, T., and Rosenberg, S. (2015). Molecular biology of cutaneous melanoma. Principles and Practice of Oncology, Wolters Kluwer."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1158\/1078-0432.CCR-18-0836","article-title":"Developments in the space of new MAPK pathway inhibitors for BRAF-mutant melanoma","volume":"25","author":"Cohen","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_59","first-page":"1071","article-title":"Cutaneous melanoma: From pathogenesis to therapy","volume":"52","author":"Leonardi","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Sullivan, R. (2015). Melanoma pathogenesis. BRAF Targets in Melanoma, Springer.","DOI":"10.1007\/978-1-4939-2143-0"},{"key":"ref_61","unstructured":"Sullivan, R., and Fisher, D. (2021, June 12). The Molecular Biology of Melanoma 2017. Available online: https:\/\/www.uptodate.com\/contents\/."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/labinvest.2016.142","article-title":"The NF1 gene in tumor syndromes and melanoma","volume":"97","author":"Kiuru","year":"2017","journal-title":"Lab. Investig."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40257-018-0414-1","article-title":"KIT as an Oncogenic Driver in Melanoma: An Update on Clinical Development","volume":"20","author":"Meng","year":"2019","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Czyz, M. (2018). HGF\/c-MET Signaling in Melanocytes and Melanoma. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19123844"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1038\/s41379-020-0581-5","article-title":"Melanoma with in-frame deletion of MAP2K1: A distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutations","volume":"33","author":"Williams","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"15003","DOI":"10.1038\/nrdp.2015.3","article-title":"Melanoma","volume":"1","author":"Schadendorf","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_67","unstructured":"Braun-Falco, O., Plewig, G., Wolf, H., and Burgdorf, W.H.C. (2009). Melanoma. Dermatology, Springer. [3rd ed.]."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Ballesteros-\u00c1lvarez, J., Dilshat, R., Fock, V., M\u00f6ller, K., Karl, L., Larue, L., \u00d6gmundsd\u00f3ttir, M.H., and Steingr\u00edmsson, E. (2020). MITF and TFEB cross-regulation in melanoma cells. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0238546"},{"key":"ref_69","first-page":"117","article-title":"Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma","volume":"436","author":"Garraway","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1158\/1078-0432.CCR-06-2682","article-title":"Microphthalmia-Associated Transcription Factor Gene Amplification in Metastatic Melanoma Is a Prognostic Marker for Patient Survival, But Not a Predictive Marker for Chemosensitivity and Chemotherapy Response","volume":"13","author":"Ugurel","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ccr.2004.10.014","article-title":"Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF","volume":"6","author":"Du","year":"2004","journal-title":"Cancer Cell"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.molmed.2006.07.008","article-title":"MITF: Master regulator of melanocyte development and melanoma oncogene","volume":"12","author":"Levy","year":"2006","journal-title":"Trends Mol. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0092-8674(03)01075-4","article-title":"Principles of Tumor Suppression","volume":"116","author":"Sherr","year":"2004","journal-title":"Cell"},{"key":"ref_74","first-page":"1","article-title":"P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation","volume":"11","author":"Bowden","year":"2011","journal-title":"BMC Cancer"},{"key":"ref_75","first-page":"191","article-title":"Prognostic prediction of the immunohistochemical expression of p16 and p53 in cutaneous melanoma: A comparison of two populations from different geographical regions","volume":"50","author":"Sirigu","year":"2006","journal-title":"Eur. J. Histochem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00008390-200410000-00010","article-title":"p53 protein expression and TP53 mutations in malignant melanomas of sun-sheltered mucosal membranes versus chronically sun-exposed skin","volume":"14","author":"Platz","year":"2004","journal-title":"Melanoma Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1158\/0008-5472.CAN-06-1538","article-title":"An Organometallic Protein Kinase Inhibitor Pharmacologically Activates p53 and Induces Apoptosis in Human Melanoma Cells","volume":"67","author":"Smalley","year":"2007","journal-title":"Cancer Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1158\/0008-5472.CAN-07-2938","article-title":"Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional Pathways","volume":"68","author":"Onder","year":"2008","journal-title":"Cancer Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nrc2501","article-title":"Hypoxia signalling through mTOR and the unfolded protein response in cancer","volume":"8","author":"Wouters","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-8-362","article-title":"Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas","volume":"8","author":"Bachmann","year":"2008","journal-title":"BMC Cancer"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/CMR.0b013e3283005270","article-title":"Prognostic biomarkers in uveal melanoma: Evidence for a stem cell-like phenotype associated with metastasis","volume":"18","author":"Chang","year":"2008","journal-title":"Melanoma Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ceb.2007.02.012","article-title":"Crossing paths with Notch in the hyper-network","volume":"19","author":"Hurlbut","year":"2007","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1172\/JCI25001","article-title":"Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression","volume":"115","author":"Balint","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1158\/0008-5472.CAN-04-0731","article-title":"Expression Profiling Reveals Novel Pathways in the Transformation of Melanocytes to Melanomas","volume":"64","author":"Hoek","year":"2004","journal-title":"Cancer Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1158\/0008-5472.CAN-08-3767","article-title":"Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes","volume":"69","author":"Pinnix","year":"2009","journal-title":"Cancer Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1172\/JCI36157","article-title":"Notch1 is an effector of Akt and hypoxia in melanoma development","volume":"118","author":"Bedogni","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The Genetic Evolution of Melanoma from Precursor Lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Schadendorf, D., Kochs, C., and Livingstone, E. (2013). Introduction to cutaneous melanoma. Handbook of Cutaneous Melanoma\u2014A Guide to Diagnosis and Treatment, Springer Healthcare.","DOI":"10.1007\/978-1-908517-98-2"},{"key":"ref_89","first-page":"36","article-title":"Malignant melanoma--future prospects","volume":"13","author":"Situm","year":"2005","journal-title":"Acta Dermatovenerol. Croat. ADC"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-018-0362-6","article-title":"An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: Version 2.0","volume":"6","author":"Sullivan","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1158\/1078-0432.CCR-18-1550","article-title":"Immunotherapy of Melanoma: Facts and Hopes","volume":"25","author":"Weiss","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/bjd.12426","article-title":"E- to N-cadherin switch in melanoma is associated with decreased expression of phosphatase and tensin homolog and cancer progression","volume":"169","author":"Guldberg","year":"2013","journal-title":"Br. J. Dermatol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/12\/6395\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:14:24Z","timestamp":1760163264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/12\/6395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,15]]},"references-count":92,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["ijms22126395"],"URL":"https:\/\/doi.org\/10.3390\/ijms22126395","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,15]]}}}